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The mammalian adaptor protein Alix [ALG-2 (apoptosis-linked-
gene-2 product)-interacting protein X] belongs to a conserved
family of proteins that have in common an N-terminal Bro1 do-
main and a C-terminal PRD (proline-rich domain), both of which
mediate partner protein interactions. Following our previous find-
ing that Xp95, the Xenopus orthologue of Alix, undergoes a phos-
phorylation-dependent gel mobility shift during progesterone-
induced oocyte meiotic maturation, we explored potential regula-
tion of Xp95/Alix by protein phosphorylation in hormone-induced
cell cycle re-entry or M-phase induction. By MALDI–TOF (mat-
rix-assisted laser-desorption ionization–time-of-flight) MS analy-
ses and gel mobility-shift assays, Xp95 is phosphorylated at mul-
tiple sites within the N-terminal half of the PRD during Xenopus
oocyte maturation, and a similar region in Alix is phosphorylated
in mitotically arrested but not serum-stimulated mammalian cells.
By tandem MS, Thr745 within this region, which localizes in a
conserved binding site to the adaptor protein SETA [SH3 (Src
homology 3) domain-containing, expressed in tumorigenic astro-
cytes] CIN85 (α-cyano-4-hydroxycinnamate)/SH3KBP1 (SH3-
domain kinase-binding protein 1), is one of the phosphorylation
sites in Xp95. Results from GST (glutathione S-transferase)-pull
down and peptide binding/competition assays further demon-
strate that the Thr745 phosphorylation inhibits Xp95 interaction
with the second SH3 domain of SETA. However, immunoprecip-
itates of Xp95 from extracts of M-phase-arrested mature oocytes
contained additional partner proteins as compared with immuno-
precipitates from extracts of G2-arrested immature oocytes. The
deubiquitinase AMSH (associated molecule with the SH3 domain
of signal transducing adaptor molecule) specifically interacts with
phosphorylated Xp95 in M-phase cell lysates. These findings
establish that Xp95/Alix is phosphorylated within the PRD during
M-phase induction, and indicate that the phosphorylation may
both positively and negatively modulate their interaction with
partner proteins.
Key words: apoptosis-linked-gene-2 product (ALG-2)-interacting
protein X (Alix), associated molecule with the Src homology 3 do-
main of signal transducing adaptor molecule (AMSH), M-phase
phosphorylation, Src homology 3 domain-containing, expressed
in tumorigenic astrocytes (SETA), Xenopus oocyte maturation,
Xp95.
INTRODUCTION
Eukaryotic cells contain adaptor or scaffold proteins whose main
functions are to bring proteins of related functions into proximity.
Members of this class of proteins often contain multiple protein
interaction sites, but lack enzymatic functions [1]. There is ample
evidence that assembly of protein complexes by adaptor or scaff-
old proteins plays important roles in fundamental cellular pro-
cesses such as cell cycle regulation and signal transduction [2–6].
During these processes, post-translational modifications, espec-
ially protein phosphorylation, often regulate interaction of adap-
tor/scaffold proteins with their binding partners [7,8]. Thus
characterization of the phosphorylation of an adaptor/scaffold
protein during a biological process may constitute an important
step towards understanding regulation of its function.
The mammalian ALG-2 (apoptosis-linked-gene-2 product)
interacting protein Alix (ALG-2-interacting protein X) belongs to
a conserved family of proteins that have in common an N-terminal
Bro1 domain (named after the yeast orthologue Bro1) and a C-
terminal PRD (proline-rich domain) [9]. The Bro1 domain of the
yeast orthologue, which consists of 387 amino acid residues, has
been structurally defined [10–12]. The Alix Bro1 domain inter-
acts with the endosomal sorting protein CHMP4b (charged multi-
vesicular body protein 4b) and Src tyrosine kinase [10,11].
This domain also contains the highly conserved sequence motif
KKDNDFIY at residues 312–319, which matches the Src auto-
phosphorylation consensus sequence [12]. In this motif, Tyr319 is
both a Src phosphorylation site and a docking site for the SH2
(Src homology 2) domain of Src [11]. The PRD contains multiple
proline-rich motifs, which are potential binding sites for SH3-do-
main-containing proteins [5,13]. Previous studies have established
that the N-terminal half of the Alix PRD interacts with the
ubiquitin-ligase-like protein TSG101 (tumour susceptibility gene
101 product) at the residues 717–720 [14,15], the adaptor
Abbreviations used: ALG-2, apoptosis-linked-gene-2 product; Alix, ALG-2-interacting protein X; AMSH, associated molecule with the Src homology 3
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Table 1 PCR primers and vectors used in making cDNA construct
Amplified region Template PCR primers (forward/reverse) Restriction sites Cloning vector Final product
Xp95 Xp95 cDNA 5′-CTCTGGATCCATGGCTACCTTCCTCGGTA-3′ BamHI/ClaI PCS2 + MT P1–Myc
1–297 5′-GGACATCGATTCACATTACATATTCATC-3′
Xp95 Xp95 cDNA 5′-TAATGGATCCATGGACTTGGCTGACAAGATCAAC-3′ BamHI/ClaI PCS2 + MT P2–Myc
298–602 5′-TCTGATCGATTTGTTACAGATATTGCCTC-3′
Xp95 Xp95 cDNA 5′-TGTAGGATCCATGCTGGATCAGATTTATGGAAGC-3′ BamHI/ClaI PCS2 + MT P3–Myc
603–867 3′-GCATATCGATGTGGAGGGAAAAAAGGCTG-3′
Xp95 P3–Myc 5′-TGTAGGATCCATGCTGGATCAGATTTATGGAAGC-3′ BamHI/ClaI PCS2 + MT P3A–Myc
603–704 5′-ATATATCGATAGAATTCATCTCGCTCTGTTTT-3′
Xp95 P3–Myc 5′-AGATGGATCCATGTTAAAGGATATACAACAAAGC-3′ BamHI/ClaI PCS2 + MT P3B–Myc
705–786 5′-AATCATCGATCTGCAGTTGGTGCTGGGTTAGA-3′
Xp95 P3–Myc 5′-CCAAGGATCCATGGCTGCTGATTCTTCACAGCCT-3′ BamHI/ClaI PCS2 + MT P3C–Myc
787–867 3′-GCATATCGATGTGGAGGGAAAAAAGGCTG-3′
Xp95 P3–Myc 5′-CCAAGGATCCATGGCTGCTGATTCTTCACAGCCT-3′ BamHI/ClaI PCS2 + MT P3BC–Myc
757–867 3′GCATATCGATGTGGAGGGAAAAAAGGCTG-3′
XCIN85 IMAGE no. 5′-ATCGGAATTCTGATGGTGGAATACATTGTGGAATA-3′ EcoRI/XbaI PCS2 + HA XCIN85
1–374 4056834 5′-ATCGTCTAGAATTACGTTGGAGTTAATTTCTTCTC-3′
Human Alix Alix cDNA 5′-AGATGGATCCATGTTAAAGGATATACAACAAAGC-3′ BamHI/ClaI PCS2 + MT Alix P3
603–869 5′-AATCATCGATCTGCAGTTGGTGCTGGGTTAGA-3′
Mouse Alix Alix cDNA 5′-ATCGGGATCCATGGCGTCGTTCATCTGGGTG-3′ BamHI/XhoI pET30a His–Alix
1–868 5′-CGATCTCGAGTCTGCTGTGGATAGTAAGACTG-3′
protein SETA (SH3-domain-containing expressed in tumorigenic
astrocytes)/CIN85 (Cbl-interacting protein of 85 kDa)/SH3KBP1
(SH3-domain kinase-binding protein 1) at the residues 740–745
[13,16], endophilins at the residues 748–761 [17] and the Src
protein tyrosine kinase at the residues 752–757 [11]. Previous
studies on the role of Alix in the formation of multivesicular
bodies and retroviral budding have demonstrated that Alix simul-
taneously binds TSG101 and CHMP4b, which are components of
ESCRT (endosomal sorting complexes required for transport) I
and III respectively and thus brings ESCRT I and ESCRT III
complexes into proximity [14,15,18]. In EGFR [EGF (epidermal
growth factor) receptor] endocytosis, Alix simultaneously binds
SETA and endophilin, and formation of this complex has negative
effects on EGFR endocytosis [19]. These findings establish the
adaptor/scaffold role of Alix.
Despite the solid evidence that Alix plays adaptor/scaffold roles
in diverse cellular processes, the regulation of Alix’s function
remains poorly understood due to lack of easily detectable post-
translational modifications of Alix in any of the characterized bio-
logical processes that involve Alix’s function. On the other hand,
we previously demonstrated that Xp95, the Xenopus orthologue
of Alix, undergoes a phosphorylation-dependent gel mobility
shift during Xenopus oocyte maturation although the biological
function of Xp95 was not characterized [12]. This established
the first biological system that involves a prominent post-trans-
lational modification of a member in the Alix/Xp95 family of pro-
teins. Xenopus oocyte maturation is a hormone-or growth-factor-
induced process by which prophase-arrested Xenopus oocytes
mature into M-phase-arrested fertilizable eggs through meiotic
divisions [20,21]. This process consists of stimulus-induced signal
transduction that leads to release of the prophase arrest and cell
cycle re-entry and induction of various regulatory and structural
events associated with M-phase induction [22]. Both of these
processes are associated with elevated protein phosphorylation
[5,23]. Since robust phosphorylation events during Xenopus
oocyte maturation often represent conserved regulatory mechan-
isms in either of these processes [24], characterization of the Xp95
phosphorylation during Xenopus oocyte maturation and investi-
gation of its conservation and functional implication may generate
important insights on the regulation of this family of proteins. In
the present study, we performed these studies and found that both
Xp95 and Alix are phosphorylated within the N-terminal half of
the PRD during M-phase induction. We also obtained evidence
that these phosphorylations modulate their interaction with
partner proteins.
MATERIALS AND METHODS
Plasmid construction, RNA production, oocyte injection
and protein extraction
The pCS2 + MT-based RNA expression construct for Myc-epi-
tope-tagged full-length Xp95 was described previously [25]. To
create RNA expression constructs for Myc-epitope-tagged Xp95
fragments, encoding cDNA fragments were amplified from
Xp95 cDNA by PCR. Xp95 mutants were created using the Quik-
Change® II site-directed mutagenesis kit (Stratagene, La Jolla,
CA, U.S.A.), and primers were designed using PrimerX software
(http://bioinformatics.org/primerx/) (Table 1). All plasmid DNAs
were amplified in Escherichia coli and verified by DNA sequenc-
ing. The cDNA fragments were subcloned into pCS2 + MT vec-
tor. The plasmid DNA was linearized with NotI before being used
for in vitro transcription using the mMESSAGE mMACHINE®
kit (Ambion, Austin, TX, U.S.A.) according to the manufacturer’s
instructions. The RNA expression construct for HA (haem-
agglutinin)-tagged XSETA (Xenopus SETA) was created by PCR
amplification of the encoding cDNA using a plasmid containing
XSETA cDNA obtained from the IMAGE (Integrated Molecular
Analysis of Genomes and their Expression) consortium (no.
4056834) as the template and subcloning of the cDNA into the
pCS2 + HA vector.
Stage VI Xenopus oocytes were obtained, cultured and injected
and proteins extracted as previously described [25]. In vitro de-
phosphorylation of proteins was performed by incubation of
samples prepared in the absence of phosphatase inhibitors with
five units of lambda phosphatase (New England Biolabs, Ipswich,
MA, U.S.A.) at room temperature (23 ◦C) for 15 min.
Immunoblotting and immunoprecipitation
Immunoblotting and immunoprecipitation were performed ac-
cording to our standard procedures [9,25]. Xp95 was immunoblot-
ted with anti-Alix monoclonal antibodies [26]. GST (glutathione
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S-transferase) or GST–Xp95-fusion proteins were immunoblotted
with anti-GST polyclonal antibodies (Santa Cruz Biotechnology,
Santa Cruz, CA, U.S.A.). Myc-epitope-tagged Xp95 products
were immunoblotted with a monoclonal anti-(Myc epitope) anti-
body (Santa Cruz Biotechnology) and immunoprecipitated with
polyclonal anti-(Myc epitope) antibodies (Santa Cruz Biotechno-
logy). HA-epitope-tagged Xenopus SETA products were immuno-
blotted with a monoclonal anti-HA-epitope antibody (Roche
Applied Sciences, Indianapolis, IN, U.S.A.) and immunoprecip-
itated with polyclonal anti-HA-epitope antibodies (Santa Cruz
Biotechnology).
Determination of Xp95 phosphorylation sites by MS
Xp95 was partially purified from 15 ml of Xenopus oocyte or egg
extracts as previously described [25]. The partially purified Xp95
samples were resolved by SDS/PAGE and stained with Coomassie
Blue. Xp95 bands were excised and digested in-gel using 400 ng
of Achromobacter protease I (LysC; Wako) for 22 h at 37 ◦C in
50 mM Tris/HCl (pH 9.0). The peptide fragments were extracted
from the gel slice and concentrated using vacuum centrifugation.
The digests were desalted using ZipTip C18 (Millipore) and eluted
with 50% acetonitrile containing 0.1% TFA (trifluoroacetic
acid). The samples were then analysed by MALDI–TOF (matrix-
assisted laser-desorption ionization–time-of-flight) MS (Applied
Biosystems 4700) using α-cyano-4-hydroxycinnamic acid. For
MS/MS (tandem MS), the digests described above were further
digested with 500 ng of thermolysin for 16 h at 37 ◦C in 30 mM
ammonium bicarbonate buffer (pH 8.0) containing 2 mM calcium
acetate, and products were desalted using ZipTip C18 and eluted
with 50% acetonitrile containing 1% acetic acid. The samples
were then analysed with a quadrupole TOF MS (Applied Biosys-
tems MDS Sciex QSTAR) using nanospray with 1000 V [27].
Cell culture, transfection and synchronization
HeLa cells were cultured in McCoys 5A (Invitrogen, Carlsbad,
CA, U.S.A.) that was supplemented with 2 mM L-glutamine
and 10% (v/v) fetal bovine serum (Atlanta Biologicals,
Lawrenceville, GA, U.S.A.). HEK-293 cells were grown in
DMEM (Dulbecco’s modified Eagle’s medium) with the same
supplements. The mammalian expression vector for Myc-epitope-
tagged Alix P3 was created by subcloning PCR-amplified cDNA
that encodes Alix P3 into the pCS2 + MT vector. HeLa cells
at 50% confluence were transfected with 5 µg of the plasmid
DNA using LipofectamineTM 2000 (Invitrogen). To obtain mitotic
cell lysates, HeLa cells were first treated with 2 mM thymidine
(Invitrogen) for 12–15 h and then switched to fresh culture
medium containing 0.1 µg/ml colcemid (Invitrogen). After 12–
15 h, mitotic cells were selectively detached by gently tapping
culture dishes 30 times. Detached cells were centrifuged at 1000 g
for 5 min and lysed in 5 vol. of SDS/PAGE sample buffer.
Production of recombinant proteins
cDNA plasmids expressing GST-tagged Xp95 fragments in E.
coli were produced using the PCR-based cloning procedure with
primers and vectors summarized in Table 1. The bacterial express-
ion vector for His-tagged Alix (His–Alix) was produced by clon-
ing the open reading frame for mouse Alix into the pET30a
vector via the PCR-based cloning procedure. cDNA plasmids
expressing the GST-tagged second SH3 domain of human SETA
and human endophilin B1b were obtained from Alexei Kurakin,
Buck Institute for Age Research (Novato, CA, U.S.A.) [28] and
Invitrogen respectively. The GST-tagged proteins were produced
and purified as we previously described [12]. Production and
purification of His–Alix were performed similarly except that
bacteria lysates made in 20 mM sodium phosphate, 500 mM
NaCl, 20 mM imidazole and 1 mM PMSF (pH 7.3) were ab-
sorbed with Ni Sepharose 6 Fast Flow resin (GE Healthcare)
and eluted with 20 mM sodium phosphate, 500 mM NaCl and
500 mM imidazole (pH 7.3).
GST pull down and peptide binding/competition
IOE (immature oocyte extract) and MEE (M-phase egg extract)
expressing HA–XSETA were incubated with 5 µg of either GST
or GST–Xp95 fragments, for 4 h at 4 ◦C. The mixtures were then
absorbed with glutathione-linked agarose beads (GE Healthcare)
for 1 h, and the beads were washed extensively as described for
immunoprecipitation. N-terminally biotinylated peptides con-
sisting of the sequence TSSIPTPAPRTVFS or TSSIPpTPA-
PRTVFS were obtained from Chemicon (Temecula, CA, U.S.A.).
Indicated amounts of these peptides dissolved in PBS were
incubated with 1 µg of GST–SETA SH3 domain no. 2 in buffer
MB (50 mM Hepes, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA
and 10% glycerol) supplemented with freshly added 1 mM
PMSF, 10 µg/ml aprotinin, 2 µg/ml leupeptin and 1 mM sodium
vanadate and pulled down with strepavidin–Sepharose beads (GE
Healthcare). Following three washes with buffer MB, bound
proteins were eluted, separated by SDS/PAGE and stained with
Coomassie Blue. These peptides were also incubated with 1 µg of
SETA SH3 no. 2 GST and 10–25 ng of His–Alix and the mixtures
were pulled down with glutathione–Sepharose beads. After three
washes of the beads with buffer MB, bound proteins were eluted
and separated by SDS/PAGE.
RESULTS
Xp95 is phosphorylated within the N-terminal half of the
PRD during Xenopus oocyte maturation
In our initial efforts to characterize the Xp95 phosphorylation
during Xenopus oocyte maturation, we characterized the region in
Xp95 that is targeted by the phosphorylation. For this objective,
one of our approaches was to analyse Xp95 purified from IOE
or MEE by MALDI–TOF MS and identify a region that is
specifically phosphorylated in the MEE Xp95. Xp95 was first par-
tially purified from IOE or MEE by consecutive chromatography
[25]. Immunoblotting of analytic quantities of partially purified
Xp95 with cross-reactive anti-Alix monoclonal antibodies showed
that the maturation-associated gel mobility shift of Xp95 was pre-
served (Figure 1A). Xp95 was then separated from other proteins
by SDS/PAGE (Figure 1B) and digested in-gel with LysC (lysyl
endopeptidase). Last, the LysC digests were analysed by MS to
identify phosphorylated peptides. In principle, phosphopeptides
identified by this method have a high probability of being physio-
logically relevant although some of phosphopeptides may not
be identified for various reasons [29]. As shown in Figure 1(C),
only one phosphopeptide was identified from the MEE Xp95,
consisting of residues 706–756 and spanning the N-terminal half
of the PRD. While this peptide from the IOE Xp95 had a single
mass of 5080 Da (Figure 1D, left panel), which matches the
theoretical mass of this peptide, this peptide from the MEE Xp95
showed three masses of 5080 Da, 5160 Da and 5240 Da (Fig-
ure 1D, right panel). Since each phosphorylation increases the
mass by 80 Da in the MALDI–TOF MS, these results indicate that
Xp95 is phosphorylated on at least two sites in this 5080 Da region
during Xenopus oocyte maturation.
In the other approach, we made iterative subdivision of Xp95
into thirds (Figure 2A) and analysed each of the fragments that
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Figure 1 Identification of a phosphopeptide within the PRD by MS
(A) Partially purified Xp95 from IOE and MEE was immunoblotted with anti-Alix monoclonal antibodies. (B) Partially purified Xp95 from IOE or MEE was separated by SDS/PAGE and proteins
were stained with Coomassie Blue. (C) A schematic illustration of the Bro1 domain and PRD in Xp95 and location of the 5080 Da peptide (residues 706–756). (D) Analysis of Xp95 peptides by
MALDI–TOF MS. The 5080 Da fragment from IOE exists as a single non-modified form (left panel), whereas the 5080 Da fragment from MEE exists as non-modified, mono- and di-phosphorylated
forms (right panel: phosphopeptides are indicated by arrowheads).
were N-terminally Myc-epitope-tagged and ectopically expressed
in Xenopus oocytes for the ability to undergo a gel mobility shift in
progesterone-matured Xenopus oocytes. An Xp95 fragment that is
capable of undergoing a gel mobility shift during Xenopus oocyte
maturation as the full-length Xp95 must contain a phosphorylation
region although a fragment of Xp95 that contains all of the
phosphorylation sites may not necessarily undergo a gel mobility
shift if, for example, it lacks the kinase interaction site or certain
structural information. As shown in Figure 2(B), the P1 (residues
1–297) or P2 (residues 298–602) fragment of Xp95 did not
undergo a gel mobility shift in progesterone-matured oocytes. In
contrast, the two products of the P3 fragment (residues 603–867),
which might result from alternative translation start sites, both
showed an easily detectable gel mobility shift in progesterone-
matured oocytes, such that the upper band was partially shifted
and the lower band was quantitatively shifted (Figure 2B, lanes 5
and 6). When the P3 fragment was further divided into thirds,
only the P3B fragment (residues 705–786), which spans the N-
terminal half of the PRD containing the 5080 Da region, showed
the gel mobility shift in mature oocytes (Figure 2C). Further,
phosphatase treatment of the P3B fragment from mature oocytes
eliminated the gel mobility shift, confirming that the shift was
due to phosphorylation (Figure 2D). These results concurred with
the conclusion that Xp95 is phosphorylated in the 5080 Da region
during Xenopus oocyte maturation and indicated that phosphoryl-
ation of this region is responsible for the maturation-associated
gel mobility shift of Xp95. As further support to this conclusion,
a P3B–P3C fusion product that was deleted from the 5080 Da
region did not undergo the gel mobility shift (Figure 2E).
Since the 5080 Da region is only 30 residues shorter than P3B
at the C-terminus, we wondered whether the 5080 Da region con-
tains all of the structural information required for the shift-produc-
ing phosphorylation. To investigate this issue, we truncated P3B
at the C-terminus by ten or 30 residues and examined the ability
of the two products to undergo the maturation-associated gel
mobility shift (Figure 2F). Neither of the truncation products
recapitulated the gel mobility shift of the full-length P3B in
mature oocytes, indicating that the last 30 residues of P3B contain
structural information critical for phosphorylation of the 5080 Da
region during Xenopus oocyte maturation.
Alix is phosphorylated in the N-terminal half of the PRD
during M-phase induction
Xp95 and Alix are 65% homologous in the N-terminal half of the
PRD (Figure 3A), suggesting that Alix can also be phosphoryl-
ated by the kinase that phosphorylates Xp95 during Xenopus oo-
cyte maturation. To test this possibility, we ectopically expressed
a Myc-epitope-tagged P3-equivalent of Alix (Myc–Alix P3) in
Xenopus oocytes by RNA injection and examined its gel mobility
shift in progesterone-matured oocytes. As shown in Figure 3(B),
Myc–Alix P3 underwent obvious gel mobility shifts in
mature oocytes, supporting the conserved nature of the Xp95
phosphorylation during Xenopus oocyte maturation.
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Figure 2 Phosphorylation of P3B within the PRD is responsible for the phosphorylation-dependent gel mobility shift of Xp95
(A) A schematic illustration of Xp95 fragments tested for the gel mobility shift in (B, C). (B, C) Indicated fragments of Xp95 that were Myc-epitope-tagged were expressed in Xenopus oocytes, and
extracts of control or progesterone-matured oocytes were immunoblotted with an anti-Myc antibody. (D) Myc–P3B was expressed in Xenopus oocytes, and IOE and MOE were made of the injected
oocytes. MOE or Myc–P3B immunoprecipitates were treated with lambda phosphatase, and products were immunoblotted with an anti-Myc antibody. (E) Myc-tagged P3B–P3C fusion was analysed
as described above for the gel mobility shift. (F) Mutant Myc–P3B that was stopped at the residue 756 (756S) or the residue 776 (776S) was analysed as described above for the gel mobility shift.
Figure 3 Alix is phosphorylated within the N-terminal half of the PRD during M-phase induction
(A) A sequence alignment of the P3B region of Xp95 with the equivalent region of Alix, in which the conserved SETA binding motif is underlined. (B) Myc–Alix P3 was expressed in Xenopus oocytes
by RNA injection, and extracts of control (IOE) or progesterone-matured (MOE) oocytes were immunoblotted with an anti-Myc antibody. (C) Protein lysates of randomly growing (IE) and mitotically
arrested (ME) HeLa cells were immunoblotted with anti-Alix antibodies. (D) Protein lysates of randomly growing (IE) and mitotically arrested (ME) HeLa cells that ectopically expressed Myc–Alix
P3 were immunoblotted with anti-Myc antibodies. (E) Protein lysates of randomly growing (IE) and mitotically arrested (ME) HeLa cells that were mock treated or ectopically expressed Alix717–
784 were immunoblotted with anti-Alix antibodies.
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Xenopus oocyte maturation consists of mitogen-induced cell
cycle entry and M-phase induction. As initial steps to determine
which of these processes involves the Xp95/Alix phosphorylation
and to determine if Alix is phosphorylated under similar circum-
stances in mammalian cells, we examined the gel mobility shift of
Alix in HeLa cells that were arrested at metaphase by the micro-
tubule poison colcemid and in NIH 3T3 cells during serum stimul-
ation of cell cycle re-entry. No gel mobility shift was detected in
Alix during the cell cycle re-entry of NIH 3T3 cells by immuno-
blotting of crude cell lysates with anti-Alix antibodies (results not
shown). In contrast, a quantitative gel mobility shift was detected
by the same method in Alix from metaphase-arrested HeLa cells
(Figure 3C). Next, we ectopically expressed Myc–Alix P3 in HeLa
cells by cDNA transfection and immunoblotted crude lysates
made of randomly growing or mitotically arrested cells with an
anti-Myc antibody. Gel mobility shifts were observed in Myc–
AlixP3 from M-phase-arrested HeLa cells (Figure 3D). Further,
we ectopically expressed a FLAG-tagged Alix with an internal
deletion at residues 717–784 (FLAG–Alix717–784), a region
very similar to the P3B region in Xp95, and examined its gel mobi-
lity shift in metaphase-arrested HeLa cells by immunoblotting
of crude cell lysates. No gel mobility shift was observed in
FLAG–Alix717–784, while an obvious gel mobility shift was
observed in the endogenous full-length Alix on the same immuno-
blot (Figure 3E). Together, these results indicated that Alix
is phosphorylated in the N-terminal half of the PRD during
M-phase induction and implied that the maturation-associated
phosphorylation of Xp95 is an event that associates with M-phase
induction.
One of the phosphorylation sites in the 5080 Da region
of Xp95 is Thr745
The 5080 Da region contains 16 potential phosphorylation sites
out of the total 50 amino acid residues as well as docking sites for
multiple SH3-domain-containing proteins. Thus, to explore the
functional implication of the Xp95/Alix phosphorylation during
M-phase induction, we characterized the amino acid residues
in the 5080 Da region that are phosphorylated during Xenopus
oocyte maturation by MS/MS. For this, the LysC-digested Xp95
from MEE was further digested with thermolysin, and resultant
smaller peptides were sequenced by MS/MS, in which one phos-
phorylation increases mass by 40 Da. Results from multiple
attempts consistently showed that Thr745 in the sequence context
SSIPTPAPRT was phosphorylated (Figures 4A and 4B) although
the other phosphorylation site in the 5080 Da region could not
be identified. Sequence alignment of the peptide with the Alix
equivalent showed that PTPAPR contained in this sequence
matches the binding sites for SETA (Figure 3A), indicating that
Xp95 is phosphorylated in the SETA binding site during Xenopus
oocyte maturation.
In our attempt to identify the other phosphorylation site, we
performed site-directed mutagenesis of all of the potential phos-
phorylation sites in the 5080 Da region (schematically diagram-
med in Figure 5A) and examined the effect on the gel mobility shift
of P3B in mature oocytes. The T745A mutation did not eliminate
the gel mobility shift (Figure 5B), and neither did other point
mutations. We then made various double or triple mutations of the
potential phosphorylation sites or small deletions as summarized
in Figure 5(C) and examined the effect on the gel mobility shift
of P3B. None of the mutations eliminated the gel mobility shift of
P3B (Figure 5D), raising the possibility that the shift-producing
phosphorylation of the 5080 Da region occurs at non-restricted
sites.
The Thr745 phosphorylation negatively regulates Xp95
interaction with SETA
To explore the functional implication of M-phase-associated
phosphorylation of Xp95/Alix, we initially determined the effect
of the Thr745 phosphorylation on Xp95 interaction with SETA.
For this objective, we produced recombinant protein encoding the
second SH3 domain of rat SETA fused with GST (GST–SETA
SH3) in bacteria and examined its interaction with Xp95 in IOE
and MOE by GST-pull down assays. The second SH3 domain of
SETA was selected because it most efficiently interacts with Alix
[3]. As shown in Figure 6(A), GST–SETA SH3 pulled down
10-fold more Xp95 from IOE than from MOE, indicating that
the Thr745 phosphorylation of Xp95 inhibits Xp95 interaction
with SETA. To test this hypothesis, we first expressed an HA-
tagged Xenopus orthologue of human SETA (HA–XSETA), which
contains equivalents of the three SH3 domains of human SETA,
in Xenopus oocytes by RNA injection, and induced oocyte matur-
ation with progesterone in half of them. We then incubated bac-
terially produced GST–Xp95P3, which is presumably not phos-
phorylated, with extracts made of these oocytes and examined
its interaction with HA–XSETA in IOE and MOE. In contrast
with the preferential interaction of GST–SETA SH3 with Xp95 in
IOE, GST–Xp95P3 pulled down similar levels of HA–XSETA
from IOE and MOE (Figure 6B). These data eliminated the
possibility that the decreased interaction of GST–SETA SH3 with
Xp95 in MOE is due to a modification of the SETA protein.
Secondly, we obtained biotinylated Thr745 non-phosphorylated
and phosphorylated peptides of Xp95 that contain the entire SETA
binding site and tested their interaction with GST–SETA SH3 by
peptide binding and competition assays. In the peptide binding
assay, increasing concentrations of these two peptides, bound to
streptavidin beads, were incubated with GST–SETA SH3, and
relative concentrations of the two peptides required for binding
to GST–SETA SH3 were determined. The phosphorylated peptide
recovered a similar level of GST–SETA SH3 at a 10-fold higher
concentration as compared with the unphosphorylated peptide
(Figure 6C). In the peptide competition assay, we incubated re-
combinant His-tagged Alix (His–Alix) with GST–SETA SH3
in the presence of increasing concentrations of either peptide
(Figure 6D). While 1 µg of the unphosphorylated peptide com-
pletely inhibited interaction of GST–SETA SH3 with His–Alix,
this amount of the phosphorylated peptide did not eliminate the
interaction (Figure 6D). In a control assay, neither of the pep-
tides interfered with the interaction between Alix and endophilin
(Figure 6E), which is mediated by an SH3 domain in endo-
philin but a different proline-rich motif in Alix. These results
support the hypothesis that the Thr745 phosphorylation negatively
regulates Xp95 interaction with SETA.
Phosphorylation of the N-terminal half of the PRD may also
positively regulate Xp95 interaction with partner proteins
To further explore the functional implication of M-phase-asso-
ciated phosphorylation of Xp95/Alix at the N-terminal half of the
PRD, we expressed Myc-epitope-tagged Xp95 (Myc–Xp95) in
Xenopus oocytes by RNA injection and immunoprecipitated the
protein from extracts of control or progesterone-matured oocytes
with anti-Myc antibodies. Coomassie Blue staining of SDS/
PAGE-separated proteins revealed that the Myc–Xp95 immuno-
complex from immature oocytes contained Myc–Xp95, heavy
and light chains of IgG and a low-molecular-mass protein of
unknown identity. Besides these proteins, the Myc–Xp95 im-
munocomplex from mature oocytes contained several additional
proteins, which sized between the IgG heavy chain and the 90 kDa
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Figure 4 Identification of Thr745 as a phosphorylation site in the 5080 Da region
Tandem mass spectra of phosphorylated (A) and unphosphorylated (B) peptides showing Thr745 phosphorylation. y5 ion presents as 541.33 in both MEE (panel A) and IOE (panel B), whereas y6
and y7 ions in MEE are 80 mass units larger than those in IOE. The doubly charged ions of the peptides (513.8 for IOE and 553.8 for MEE) and y7 ions (370.237 in IOE and 410.223 in MEE) show
40 mass unit differences between IOE and MEE (arrows indicate ions).
molecular mass marker (Figure 7A) and were not recognized
by the anti-Myc antibodies (results not shown). These results
indicated that M-phase-associated phosphorylation of Xp95
may positively regulate Xp95 interaction with partner proteins.
Although testing this hypothesis, which requires determination
of the identity of the additional proteins in the Myc–Xp95 im-
munocomplex from mature oocytes, mapping each of their inter-
action sites in Xp95 and comparing each of their interactions with
Xp95 from immature and mature oocytes, is beyond the scope of
the present study, this hypothesis inspired us to examine the impact
of Xp95 phosphorylation on the deubiquitinase AMSH (associ-
ated molecule with the SH3 domain of signal transducing adaptor
molecule). AMSH has been functionally linked to the endosomal
sorting machinery like Alix [30–34]; however, no physical con-
nection, either direct or indirect, had been detected between
AMSH and Alix [30,31]. We ectopically expressed Myc–Xp95 in
HEK-293 cells (human embryonic kidney cells) that were either
growing randomly or mitotically arrested and determined the in-
teraction of Myc–Xp95 with GST-tagged AMSH (GST–AMSH)
or GST–SETA SH3 (used as a control). While GST–SETA SH3
specifically interacted with GFP-Xp95 in interphase cell lysates
as expected, the converse was observed with GST–AMSH, as
GST–AMSH specifically interacted with Myc–Xp95 in mitotic
cell lysates (Figure 7B). Further, His–Alix did not interact with
c© 2007 Biochemical Society
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Figure 5 None of the potential phosphorylation sites in the 5080 Da region is required for the gel mobility shift of P3B
(A) A schematic illustration of the residues that were individually mutated in the 5080 Da region of Myc–P3B. (B) Wild-type Myc–P3B (WT P3B) and the T745A mutant form of Myc–P3B (T745A
P3B) were assayed in parallel for the gel mobility shift as described in Figure 2. (C) A summary of multiple-site mutations made in the 5080 Da region of Myc–P3B. ‘A’ represents a point mutation to
alanine, and ‘X’ represents a deletion mutation. (D) Indicated Myc–P3B mutants were assayed for the gel mobility shift during oocyte maturation as described in Figure 2.
GST–AMSH in vitro, suggesting that a post-translational modific-
ation is required for AMSH–Alix interaction (results not shown).
These results support the hypothesis that M-phase-associated
phosphorylation of the PRD is capable of positively modulating
Xp95/Alix interaction with a group of partner proteins.
DISCUSSION
The phosphorylation of Xp95, which underlies its gel mobility
shift during Xenopus oocyte maturation, is likely to be a
regulatory event of Xp95’s function. Therefore elucidation of the
regions/residues involved should provide important information
on Xp95 regulation. As Xp95 is 87% homologous with mam-
malian Alix, we furthermore expected that post-translational
modifications that regulate Xp95 are conserved in Alix. However,
as biochemical analyses are easier in the Xenopus system, where
large amounts of proteins can be easily generated, we pursued
our discoveries there and sought confirmation of our findings in
mammalian cells.
By the direct approach of MS, we discovered one region in
Xp95 that is phosphorylated on at least two sites during Xenopus
oocyte maturation, and identified Thr745, which is within the SETA
binding motif [13,16], as one of the phosphorylation sites. We
further demonstrated by Xp95–SETA interaction and peptide
binding/competition assays that the Thr745 phosphorylation is
an M-phase-associated event that inhibits Xp95 binding to the
second SH3 domain of SETA. These findings indicate that phos-
phorylation of Xp95/Alix at the SETA binding site inhibits Xp95/
SETA interaction and suggest that the cellular process that
involves this interaction is down-regulated during M-phase
induction. We should note that since Thr745 of Xp95 lies in an S/T-
P motif, we tested whether CDC2 (cell division cycle 2 kinase)/
cyclin B or p42 MAPK (mitogen-activated protein kinase), the
two major proline-directed protein kinases in mature Xenopus
oocytes, could phosphorylate Xp95 in vitro. Negative results were
obtained from multiple attempts with either of the kinases (results
not shown), suggesting that Xp95 is targeted by a different mitotic
kinase.
Since MS-based analysis of protein phosphorylation is often
low-yield, we additionally mapped the region and sites in Xp95
whose phosphorylation is responsible for the gel mobility shift of
Xp95 during Xenopus oocyte maturation. By iterative subdivision
of Xp95 into thirds and testing various fragments for the gel
mobility shift, we found that the P3B fragment (residues 706–
786), which spans the N-terminal half of the PRD, retains the
ability to undergo the phosphorylation-dependent gel mobility
shift during Xenopus oocyte maturation. This finding is consistent
with the MS data, as the P3B fragment not only contains the
entire 5080 Da region (residues 706–756) but, as shown by further
mapping data, also requires its presence for the gel mobility shift
of P3B.
The 5080 Da region contains 16 potential phosphorylation sites
out of the total 50 amino acid residues, representing a great enrich-
ment of phosphorylatable residues: 32% as compared with 18%
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Figure 6 Xp95 phosphorylation at Thr745 inhibits SETA binding
(A) After GST or GST-tagged second SH3 domain of SETA (SETA SH3) was incubated with extracts of control or progesterone-matured oocytes, crude lysates or proteins pulled down by
glutathione–Sepharose beads were immunoblotted with anti-Alix antibodies (upper panel) or stained with Coomassie Blue (lower panel). (B) After GST or GST-tagged P3 fragment of Xp95
was incubated with extracts of control or progesterone-matured oocytes that ectopically expressed HA-tagged Xenopus SETA (HA–XSETA), crude cell lysates or proteins pulled down by
glutathione–Sepharose beads were immunoblotted with anti-HA antibodies (upper panel) or stained with Coomassie Blue (lower panel). (C) Increasing amounts (10, 100 and 1000 ng) of the Thr745
non-phosphorylated (T745 peptide) or phosphorylated (pT745 peptide) peptide immobilized on to strepavidin beads were incubated with GST–SETA SH3, and bound proteins were immunoblotted
with anti-GST antibodies. (D) GST–SETA SH3 was incubated with His-tagged Alix in the presence of increasing amounts (10, 100 and 1000 ng) of T745 peptide (lanes 3–5) or pT745 peptide
(lanes 6–8), and proteins pulled down by glutathione–Sepharose beads were immunoblotted with anti-Alix antibodies (upper panel) or stained with Coomassie Blue (lower panel). (E) GST or
GST-tagged endophilin (GST–Endo) was analysed as described in (D).
Figure 7 Phosphorylation of Xp95 correlates with its interaction with additional partner proteins
(A) Ectopically expressed Xp95 was immunoprecipitated from extracts of immature (IOE) or mature (MOE) oocytes, and the immunocomplexes were analysed by SDS/PAGE and Coomassie
Blue staining. (B) GST, GST–SETA SH3 or GST–AMSH was incubated with crude lysates of randomly growing (IE) or mitotically arrested (ME) HEK-293 cells, and proteins pulled down by
glutathione–Sepharose were immunoblotted with an anti-Myc antibody (upper panel) or stained with Coomassie Blue (lower panel).
in the protein overall. Since MS revealed only one of the phos-
phorylation sites, we tried to identify the second phosphorylation
site in the 5080 Da region by mutagenesis and gel mobility
shift assays. Mutation of Thr745 to alanine did not eliminate the
gel mobility shift of P3B, supporting the existence of a second
site. However, mutation of any one of the other potential phos-
phorylation sites in this region also failed to eliminate the shift,
suggesting that phosphorylation in the 5080 Da region can occur
at varied sites among which Thr745 is phosphorylated more often.
The potentially non-strict nature of the P3B phosphorylation also
makes it possible that phosphorylation of the 5080 Da region
in Xp95 during Xenopus oocyte maturation is a heterogeneous
event, with individual proteins showing different modifications.
This may account for the lack of success in identifying the second
phosphorylation site by the MS/MS.
One plausible explanation for the region-specific but site-
flexible phosphorylation of Xp95 during M-phase induction is
that the responsible kinase forms a stable complex with Xp95. In
principle, the specificity of a protein kinase towards a substrate
depends on the substrate concentration. When a kinase forms a
c© 2007 Biochemical Society
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stable complex with its substrate, the bound substrate is at an
infinitely high concentration and thus accessible domains may
be phosphorylated non-specifically. This phenomenon has been
described in phosphorylation of the yeast Swe1 by mitotic CDK
(cyclin-dependent kinase) complex [35]. Under this hypothesis,
the results showing that the 5080 Da region alone did not
recapitulate the shift of P3B suggest the possibility that the portion
of P3B outside the 5080 Da region contains structural information
required for kinase interaction. From a functional point of view,
the non-strict nature of the phosphorylation of the 5080 Da region
may imply that phosphorylation functions to increase the negative
charge in this region rather than only affecting specific docking
sites for partner proteins. In principle, the increased negative
charge in the 5080 Da region may potentially modulate the con-
formation of Xp95, its dimerization, or its intramolecular interac-
tion, which in turn affects Xp95 interaction with partner proteins.
These possibilities will be explored in future studies. By compar-
ing the prominent components in Xp95 immunoprecipitates, we
observed additional partner proteins in the Xp95 complex from
mature oocytes as compared with immature oocytes. We also
found an example of a specific protein, AMSH, which preferen-
tially binds to phosphorylated Xp95 in M-phase cell lysates. Al-
though we have not yet resolved whether the interaction between
Xp95 and AMSH is direct or indirect (since bacterial protein
used for in vitro binding assays are presumably not phos-
phorylated), these results strengthen the hypothesis that site-
flexible phosphorylation of the 5080 Da region promotes Xp95
interaction with a group of partner proteins.
Xenopus oocyte maturation consists of both progesterone-
induced signal transduction and meiotic inductions [22], and we
previously suggested that the Xp95 gel mobility shift associates
with progesterone-induced signal transduction based on the
correlation of the Xp95 phosphorylation with activation of p42
MAPK [25]. However, these two processes overlap during pro-
gesterone-induced Xenopus oocyte maturation, making it difficult
to unambiguously address this issue using this experimental
system. By observing the Alix gel mobility shift during growth
factor-induced cell cycle re-entry and mitotic arrest of cultured
somatic cells, we resolved that the phosphorylation-dependent
gel mobility shift of Alix/Xp95 is an M-phase-associated event.
Alix has been demonstrated to be involved in multiple stages of
endosome trafficking, including endocytosis of activated growth
factor receptors and formation of multivesicular late endosomes
[14,19,36,37]. Alix has also been shown to bind focal adhesion
kinases and regulate cell adhesion [26,38]. Our recent studies
have demonstrated that Alix is an F-actin-binding protein in mam-
malian fibroblast cells that promotes actin-cytoskeleton assembly
[26]. Since M-phase induction involves disassembly of cytoplas-
mic membrane trafficking systems, reorganization of the actin
cytoskeleton and inhibition of cell adhesion [39–41], the asso-
ciation of Xp95/Alix phosphorylation with M-phase raises the
possibility that this modification of Xp95/Alix modulates its roles
in these cellular processes during M-phase induction.
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